Paper938024
Ototoxicity of amikacin.
Black RE and 4 others. Antimicrob Agents Chemother, 1976. Cited by 138 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ototoxicity of amikacin. Papers, record 938024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/938024
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Hearing Disorders | Major topic |
| Kanamycin | Major topic |
| Cochlea | |
| Hearing Tests | |
| Humans | |
| Risk |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,825,416 | Kanamycin. II. Ototoxicity. | Am Rev Respir Dis | 1960 | https://conductscience.org/library/papers/13825416 | PubMed |
| 2 | 4,208,506 | Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4208506 | PubMed |
| 3 | 4,544,451 | Ototoxicity studies with BB-K8, a new semisynthetic aminoglycoside antibiotic. | J Antibiot (Tokyo) | 1973 | https://conductscience.org/library/papers/4544451 | PubMed |
| 4 | 4,486,599 | Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside. | J Antibiot (Tokyo) | 1972 | https://conductscience.org/library/papers/4486599 | PubMed |
| 5 | 4,462,465 | Pharmacology of amikacin in humans. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4462465 | PubMed |
| 6 | 4,790,604 | Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4790604 | PubMed |
| 7 | 4,793,881 | Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4793881 | PubMed |
| 8 | 4,790,938 | In vitro studies of BB-K8, a new aminoglycoside antibiotic. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4790938 | PubMed |
| 9 | 1,097,551 | Radioimmunoassay, acetylating radio-enzymatic assay, and microbioassay of gentamicin: a comparative study. | J Lab Clin Med | 1975 | https://conductscience.org/library/papers/1097551 | PubMed |
| 10 | 1,200,524 | Amikacin therapy for serious gram-negative bacillary infections. | Ann Intern Med | 1975 | https://conductscience.org/library/papers/1200524 | PubMed |
| 11 | 5,227,783 | Toxicity of kanamycin in adults. | Ann N Y Acad Sci | 1966 | https://conductscience.org/library/papers/5227783 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,211,500 | Comedication that increase the risk of cisplatin-induced hearing loss in pediatric cancer patients: a narrative literature review and meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42211500 | PubMed |
| 39,977,423 | Mycetoma managment: Therapeutic challenges and the role of pharmacovigilance. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/39977423 | PubMed |
| 38,663,898 | Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm. | BMJ Case Rep | 2024 | https://conductscience.org/library/papers/38663898 | PubMed |
| 38,500,260 | The Use of Xenonucleic Acids Significantly Reduces the In Vivo Drift of Electrochemical Aptamer-Based Sensors. | Angew Chem Int Ed Engl | 2024 | https://conductscience.org/library/papers/38500260 | PubMed |
| 35,734,010 | Hearing aid support for patients with DR-TB in Ethiopia. | Public Health Action | 2022 | https://conductscience.org/library/papers/35734010 | PubMed |
| 35,423,693 | A wrinkled structure of gold film greatly improves the signaling of electrochemical aptamer-based biosensors. | RSC Adv | 2020 | https://conductscience.org/library/papers/35423693 | PubMed |
| 35,280,037 | Hearing screening outcomes in pediatric critical care survivors: a 1-year report. | Acute Crit Care | 2022 | https://conductscience.org/library/papers/35280037 | PubMed |
| 34,827,790 | Evidence of Hearing Loss and Unrelated Toxoplasmosis in a Free-Ranging Harbour Porpoise (Phocoena phocoena). | Animals (Basel) | 2021 | https://conductscience.org/library/papers/34827790 | PubMed |
| 30,948,747 | Area-dependent change of response in the rat's inferior colliculus to intracochlear electrical stimulation following neonatal cochlear damage. | Sci Rep | 2019 | https://conductscience.org/library/papers/30948747 | PubMed |
| 30,158,267 | Unusual discovery of a vestibular schwannoma following eradication therapy for Mycobacterium abscessus. | BMJ Case Rep | 2018 | https://conductscience.org/library/papers/30158267 | PubMed |
| 29,404,977 | Drug-Induced Ototoxicity: Diagnosis and Monitoring. | Drug Saf | 2018 | https://conductscience.org/library/papers/29404977 | PubMed |
| 28,165,504 | Implementation of a method to visualize noise-induced hearing loss in mass stranded cetaceans. | Sci Rep | 2017 | https://conductscience.org/library/papers/28165504 | PubMed |
| 28,012,509 | Changes in the inner ear structures in cystic fibrosis patients. | Int J Pediatr Otorhinolaryngol | 2017 | https://conductscience.org/library/papers/28012509 | PubMed |
| 26,654,443 | Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort. | BMC Pharmacol Toxicol | 2015 | https://conductscience.org/library/papers/26654443 | PubMed |
| 26,248,372 | Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26248372 | PubMed |
| 26,168,747 | A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides? | Afr J Paediatr Surg | 2015 | https://conductscience.org/library/papers/26168747 | PubMed |
| 25,330,342 | Mycetoma medical therapy. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/25330342 | PubMed |
| 25,300,708 | Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/25300708 | PubMed |
| 24,250,429 | The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients. | Iran J Pharm Res | 2011 | https://conductscience.org/library/papers/24250429 | PubMed |
| 23,055,904 | Use of ototoxic medications in neonates-the need for follow-up hearing test. | J Pediatr Pharmacol Ther | 2009 | https://conductscience.org/library/papers/23055904 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/938024
GET https://conductscience.org/api/papers/v1/938024/cited_by?page=2